Quantum-Si incorporated (QSI)
Market Cap | 185.53M |
Revenue (ttm) | 2.27M |
Net Income (ttm) | -89.93M |
Shares Out | 142.71M |
EPS (ttm) | -0.63 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 13,110,177 |
Open | 1.240 |
Previous Close | 1.290 |
Day's Range | 1.200 - 1.340 |
52-Week Range | 0.612 - 2.580 |
Beta | 3.23 |
Analysts | Buy |
Price Target | 3.25 (+150.0%) |
Earnings Date | Nov 12, 2024 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applic... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price forecast is $3.25, which is an increase of 150.00% from the latest price.
News
Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRx...
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Expands International Distribution Network
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Expands International Distribution Network.
Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™.
Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening.
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst...
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platfo...
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (N...
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop ...
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
BRANFORD, Conn. & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKY...
Quantum-Si and Planet Innovation to Partner on Proteus™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will pa...
Quantum-Si Honored with Frost & Sullivan's 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sulliv...
Quantum-Si incorporated (QSI) Q3 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conf...
Quantum-Si Reports Third Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter...
University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si's Next-Gen Protein Sequencer™ Platinum®
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication o...
Quantum-Si to Participate in Upcoming Investment Conferences
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two up...
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor ...
Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Soc...
Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--QSI to report Q3 2024 Operating Results on 11/12/24.
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--QSI announces inducement grants.
Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024.
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces proteomics webinar.
Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biote...
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.
Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si announces promotions and appointment of CCO.